Paras Healthcare schedules October IPO with a debt repayment focus

Paras Healthcare has set out an October IPO that combines company financing with sales by existing shareholders. Its SEBI filing published on 15 October introduces an offer scheduled for public bidding from 21 to 23 October 2026. As of 20 October, that public subscription window remains ahead.

The abridged prospectus proposes a fresh issue of up to ₹5 billion and an offer for sale of up to ₹9.5 billion. Only the new share component supplies company capital. The stated uses include ₹3.209 billion for company borrowings and ₹541 million for borrowings at wholly owned subsidiary PMHPL. General corporate purposes account for the remaining permitted allocation.

Paras operates hospitals under the Paras Health brand. Its abridged prospectus describes eight hospitals and 2,211 beds as of 30 June 2026, with locations spanning North India, Bihar and Jharkhand. The network provides specialist services including cardiac care, oncology, neuroscience and orthopaedics.

The same issuer information describes planned additional hospitals in Gurugram and Ludhiana, using lease arrangements. Our reading is that debt repayment and hospital expansion should be assessed together, without treating the entire IPO headline as a construction budget. Reducing borrowings can change financing pressure, but a bigger hospital network also needs doctors, patient volumes and efficient operations.

For readers following the transaction, the practical next questions concern the final price, subscribed demand and completed allotment. For the underlying business, occupancy, service mix and the pace of new hospital development deserve attention beyond the listing date. The proposed offer gives the company an opportunity to strengthen its finances while allowing shareholders to sell; the final allocation of proceeds will determine how that plan translates into the balance sheet.